Published in
Elsevier, European Journal of Cancer, (171), p. 96-105, 2022
DOI: 10.1016/j.ejca.2022.05.008
Links
Tools
Tumour burden and antigen-specific T cell magnitude represent major parameters for clinical response to cancer vaccine and TCR-engineered T cell therapy
Journal article published in 2022 by
Marion Mallet,
Rasha E. Boulos 
,
Vincent Alcazer ,
Paola Bonaventura,
Yann Estornes ,
Nicolas Chuvin ,
Stéphane Depil
,
Vincent Alcazer ,
Paola Bonaventura,
Yann Estornes ,
Nicolas Chuvin ,
Stéphane Depil
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 